340B Health

Who We Are

340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.

Learn more about us

340B Informed

Mylan to Pay $19.3 Million Plus Interest for 340B Overcharges

August 18, 2017—Hospitals and other healthcare providers in the 340B drug discount program will receive $19.3 million plus interest from drug manufacturer Mylan for overcharges due to Mylan’s misclassification of its epinephrine auto-injector EpiPen as a generic rather than brand-name product....
Read More

340B Employed

The Exchange